In
pernicious anemia, which is usually an
autoimmune disease,
autoantibodies directed against intrinsic factor or parietal cells themselves lead to an intrinsic factor deficiency,
malabsorption of vitamin B12, and subsequent
megaloblastic anemia.
Atrophic gastritis can also cause intrinsic factor deficiency and anemia through damage to the parietal cells of the stomach wall.
Pancreatic exocrine insufficiency can interfere with normal dissociation of vitamin B12 from its binding proteins in the small intestine, preventing its absorption via the intrinsic factor complex. Other risk factors contributing to pernicious anemia are anything that damages or removes a portion of the stomach's parietal cells, including
bariatric surgery, gastric tumors, gastric ulcers, and excessive consumption of alcohol. Mutations in the
GIF gene are responsible for a rare inheritable disease called
intrinsic factor deficiency which results in malabsorption of vitamin B12.
Treatment In most countries,
intramuscular injections of vitamin B12 are used to treat
pernicious anemia. There are not enough studies on whether pills are as effective in improving or eliminating symptoms as parenteral treatment. Vitamin B12 can also be given
sublingually, but there is no evidence that this route of administration is superior to the oral route, and only Canada and Sweden routinely prescribe this route of administration. Because vitamin B12 absorption is a multistep process that involves the stomach, pancreas and small intestine, and is mediated by two carriers:
Haptocorrin and intrinsic factor, and because
Haptocorrin (
transcobalamin I) binds to vitamin B12, and Vitamin B12 is acid-sensitive, when vitamin B12 binds to
Haptocorrin it can safely pass through the acidic stomach to the duodenum, given time in the mouth. == References ==